HIV-hepatitis B virus coinfection: epidemiology, pathogenesis, and treatment KP Singh, M Crane, J Audsley, A Avihingsanon, J Sasadeusz, SR Lewin Aids 31 (15), 2035-2052, 2017 | 255 | 2017 |
Integrated immune dynamics define correlates of COVID-19 severity and antibody responses M Koutsakos, LC Rowntree, L Hensen, BY Chua, CE Van De Sandt, ... Cell Reports Medicine 2 (3), 2021 | 146 | 2021 |
Medication adherence, condom use and sexually transmitted infections in Australian preexposure prophylaxis users L Lal, J Audsley, DA Murphy, CK Fairley, M Stoove, N Roth, R Moore, ... Aids 31 (12), 1709-1714, 2017 | 133 | 2017 |
Cell-based influenza vaccines: progress to date JM Audsley, GA Tannock Drugs 68, 1483-1491, 2008 | 105 | 2008 |
Biomarkers of inflammation and coagulation are associated with mortality and hepatitis flares in persons coinfected with HIV and hepatitis viruses BB Andrade, KH Hullsiek, DR Boulware, A Rupert, MA French, ... The Journal of infectious diseases 207 (9), 1379-1388, 2013 | 63 | 2013 |
The anti-HIV activity of entecavir: a multicentre evaluation of lamivudine-experienced and lamivudine-naive patients J Sasadeusz, J Audsley, A Mijch, R Baden, J Caro, H Hunter, G Matthews, ... Aids 22 (8), 947-955, 2008 | 63 | 2008 |
Viral adaptation to host immune responses occurs in chronic hepatitis B virus (HBV) infection, and adaptation is greatest in HBV e antigen-negative disease CP Desmond, S Gaudieri, IR James, K Pfafferott, A Chopra, GK Lau, ... Journal of Virology 86 (2), 1181-1192, 2012 | 56 | 2012 |
The role of cell culture vaccines in the control of the next influenza pandemic JM Audsley, GA Tannock Expert Opinion on Biological Therapy 4 (5), 709-717, 2004 | 54 | 2004 |
Prolonged use of tenofovir in HIV/hepatitis B virus (HBV)‐coinfected individuals does not lead to HBV polymerase mutations and is associated with persistence of lamivudine HBV … J Audsley, N Arrifin, LKW Yuen, A Ayres, SM Crowe, A Bartholomeusz, ... HIV medicine 10 (4), 229-235, 2009 | 49 | 2009 |
The effect of antiretroviral intensification with dolutegravir on residual virus replication in HIV-infected individuals: a randomised, placebo-controlled, double-blind trial TA Rasmussen, JH McMahon, JJ Chang, J Audsley, A Rhodes, ... The lancet HIV 5 (5), e221-e230, 2018 | 46 | 2018 |
HBV mutations in untreated HIV-HBV co-infection using genomic length sequencing J Audsley, M Littlejohn, L Yuen, J Sasadeusz, A Ayres, C Desmond, ... Virology 405 (2), 539-547, 2010 | 39 | 2010 |
The growth of attenuated influenza vaccine donor strains in continuous cell lines JM Audsley, GA Tannock Journal of virological methods 123 (2), 187-193, 2005 | 39 | 2005 |
Intrahepatic CXCL10 is strongly associated with liver fibrosis in HIV-Hepatitis B co-infection KP Singh, JM Zerbato, W Zhao, S Braat, C Deleage, GS Tennakoon, ... PLoS pathogens 16 (9), e1008744, 2020 | 37 | 2020 |
A gathering storm: HIV infection and nonalcoholic fatty liver disease in low and middle-income countries N Kapoor, J Audsley, P Rupali, J Sasadeusz, TV Paul, N Thomas, ... Aids 33 (7), 1105-1115, 2019 | 30 | 2019 |
Long-term TDF-inclusive ART and progressive rates of HBsAg loss in HIV-HBV coinfection—lessons for functional HBV cure? J Audsley, A Avihingsanon, M Littlejohn, S Bowden, GV Matthews, ... JAIDS Journal of Acquired Immune Deficiency Syndromes 84 (5), 527-533, 2020 | 26 | 2020 |
Effects of long-term tenofovir-based combination antiretroviral therapy in HIV-hepatitis B virus coinfection on persistent hepatitis B virus viremia and the role of hepatitis B … J Audsley, SJ Bent, M Littlejohn, A Avihingsanon, G Matthews, S Bowden, ... Aids 30 (10), 1597-1606, 2016 | 25 | 2016 |
SARS-CoV-2 infection results in immune responses in the respiratory tract and peripheral blood that suggest mechanisms of disease severity W Zhang, BY Chua, KJ Selva, L Kedzierski, TM Ashhurst, ER Haycroft, ... Nature Communications 13 (1), 2774, 2022 | 23 | 2022 |
Liver fibrosis regression measured by transient elastography in human immunodeficiency virus (HIV)-hepatitis B virus (HBV)-coinfected individuals on long-term HBV-active … J Audsley, C Robson, S Aitchison, GV Matthews, D Iser, J Sasadeusz, ... Open Forum Infectious Diseases 3 (1), ofw035, 2016 | 23 | 2016 |
Medication adherence, condom use and sexually transmitted infections in Australian PrEP users: interim results from the Victorian PrEP Demonstration Project L Lal, J Audsley, D Murphy, CK Fairley, M Stoove, N Roth, R Moore, ... AIDS 31 (12), 1709-14, 2017 | 21 | 2017 |
Factors associated with elevated ALT in an international HIV/HBV co-infected cohort on long-term HAART J Audsley, EC Seaberg, J Sasadeusz, GV Matthews, A Avihingsanon, ... PLoS one 6 (11), e26482, 2011 | 21 | 2011 |